stockrow
Friday 6 November 2026
Export NRC’s income statement to Excel — free account
National Research Corporation
NRC Healthcare Health Information Services
National Research Corporation’s revenue for fiscal 2025 (year ended December 2025) was $137.4 million, down 3.96% from fiscal 2024.
- Revenue
- +11.0%
- EPS
- +20.3%
- Free cash flow
- −31.4%
- Total debt
- +29.1%
Quarter to September 2026, against a year earlier
25.83
0.35
+1.37%
Follow NRC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 5 | 5 | 6 |
| 49.88% | 40.43% | 39.82% | 236.21% | ||
| 8.45% | 6.47% | 4.00% | 4.46% | ||
ROIC |
16.64% | 14.39% | 10.32% | 11.64% | |
Return on Tangible Assets |
46.93% | 40.00% | 20.34% | 26.42% | |
Average Days of Receivables |
30.91 | 29.79 | 35.59 | 46.36 | |
Free Cash Flow per Share |
0.70 | 0.80 | 0.98 | 0.85 | |
Free Cash Flow |
15.74 | 17.43 | 21.64 | 18.45 | |
Capital Expenditures |
(10.71) | (9.55) | (7.87) | (5.32) | |
| Other line items | |||||
Cash ROIC |
16.90% | 19.35% | 22.57% | 19.91% | |
Accounts Receivable Turnover |
12.04 | 12.17 | 10.56 | 9.27 | |
Accounts Payable Turnover |
44.33 | 24.88 | 42.74 | 45.04 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
8.15 | 15.35 | 9.04 | 9.14 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.35) | (0.38) | (0.38) | (0.39) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
39.89% | 41.74% | 45.06% | 43.71% | |
Share Based Compensation of Revenue |
2.41% | 3.43% | 8.44% | 7.48% | |
Interest Coverage |
4.74 | 3.82 | 2.73 | 2.90 | |
Operating CF/Net income |
2.34 | 3.09 | 5.32 | 3.88 | |
Depreciation/Fixed assets |
0.19 | 0.21 | 0.22 | 0.22 | |
Capex/Depreciation |
(1.39) | (1.14) | (0.90) | (0.62) | |
Revenue per Share |
6.14 | 6.36 | 6.36 | 6.62 | |
Operating CF per Share |
1.18 | 1.24 | 1.34 | 1.09 | |
Capex per Share |
(0.48) | (0.44) | (0.36) | (0.24) | |
Capex to Sales |
0.08 | 0.07 | 0.06 | 0.04 |
Columns are period end dates · fundamentals updated 6 Nov 2026